C. difficile diagnostic kit recalled due to storage temperature deviation
Biomerieux is recalling a C. difficile diagnostic test kit after units were stored outside temperature and time limits, potentially compromising test performance.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The primary hazard is storage-condition deviation that may compromise diagnostic test performance and reliability; however, this is a precautionary recall without confirmed patient harm or adverse test results.
Plain-English summary
Biomerieux Inc is recalling the PPM CLINICAL CRAPONNE CHROMID C. DIFFICILE diagnostic kit (Catalog 43871) distributed nationwide in the United States. The recall is being issued because some units were stored outside specified temperature and time parameters, which may compromise the product's ability to perform as intended.
The affected batch is identified as Batch Number 1009501430, with UDI/DI 03573026316969. Healthcare facilities and laboratories that received affected units should discontinue use and contact Biomerieux for replacement units or further instructions.
Although no illnesses or injuries have been reported, the storage deviation means the diagnostic test's accuracy cannot be guaranteed. Healthcare providers should be aware that test results from potentially affected units may not be reliable. Patients who have been tested with potentially affected units may wish to consult with their healthcare provider to determine if retesting is necessary.
The recalled product
- Product
- PPM CLINICAL CRAPONNE CHROMID C.DIFFICILE 20 PLT, CATALOG 43871
- Manufacturer
- Biomerieux Inc
- Category
- Medical Device — Diagnostic Test
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI/DI 03573026316969
- Batch Numbers: 1009501430
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 94 recalled by Biomerieux Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 94 products in this recall →Related recalls
Same manufacturer · Biomerieux Inc
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighSusceptibility test cards recalled over false resistant antibiotic results
FDA (Devices) · 2026-02-11
- HighAntimicrobial susceptibility test cards recalled over false colistin resistance results
FDA (Devices) · 2025-10-08
- SevereVITEK 2 AST Test Kits: Ceftriaxone Concentration Error Risk
FDA (Devices) · 2024-05-01
- HighMedical Device Middleware: MYLA Software Fails to Apply AST Filter Rules
FDA (Devices) · 2023-03-08
Same hazard · storage temperature deviation
See all →- HighPrescription Inhalation Powder Recalled for Storage Temperature Deviation
FDA (Drugs) · 2024-01-03
- HighLansoprazole Suspension Recalled Due to Temperature Storage Deviations
FDA (Drugs) · 2024-01-03
- HighWarfarin Sodium Tablets Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateAlbuterol sulfate inhalation aerosol recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- ModerateFDA recalls Asmanex asthma inhalation powder for improper storage conditions
FDA (Drugs) · 2024-01-03